iShares NASDAQ Biotechnology Index (IBB) Holdings Lifted by Altavista Wealth Management Inc.

Altavista Wealth Management Inc. raised its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 13.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,570 shares of the financial services provider’s stock after buying an additional 2,540 shares during the period. Altavista Wealth Management Inc.’s holdings in iShares NASDAQ Biotechnology Index were worth $2,302,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Quadrant Capital Group LLC purchased a new stake in shares of iShares NASDAQ Biotechnology Index in the first quarter valued at approximately $111,000. Bedel Financial Consulting Inc. purchased a new stake in shares of iShares NASDAQ Biotechnology Index in the first quarter valued at approximately $119,000. Edge Advisors LLC boosted its holdings in shares of iShares NASDAQ Biotechnology Index by 200.0% in the fourth quarter. Edge Advisors LLC now owns 1,305 shares of the financial services provider’s stock valued at $139,000 after purchasing an additional 870 shares during the period. All Terrain Financial Advisors LLC purchased a new stake in shares of iShares NASDAQ Biotechnology Index in the fourth quarter valued at approximately $140,000. Finally, Pittenger & Anderson Inc. boosted its holdings in shares of iShares NASDAQ Biotechnology Index by 188.0% in the fourth quarter. Pittenger & Anderson Inc. now owns 1,440 shares of the financial services provider’s stock valued at $154,000 after purchasing an additional 940 shares during the period. Institutional investors and hedge funds own 60.10% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index opened at $111.26 on Monday, according to MarketBeat Ratings. iShares NASDAQ Biotechnology Index has a 52-week low of $96.84 and a 52-week high of $119.30.



iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply